Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

Inclusion Criteria: * Has a clinical diagnosis of RVO in the study eye * Has a CST of ≥ 300 µm in the study eye * Has an ETDRS BCVA score of ≥ 20 letters read and ≤ 70 letters read in the study eye; * Is naïve to local pharmacologic treatment for RVO in the study eye; Exclusion Criteria: * Any active ocular disease or infection in the study eye other than RVO * History of glaucoma, intraocular pressure \> 21 mmHg or ocular hypertension requiring more than one medication * Any uncontrolled systemic disease that, in the opinion of the Investigator, would preclude participation in the study * Any evidence of neovascularization in the study eye